TOTH, Gabor G., Bernard DE BRUYNE, Petr KALA, Flavio RIBICHINI, Filip CASSELMAN, Ruben RAMOS, Zsolt PIROTH, Stephane FOURNIER, Anna PICCOLI, Carlos VAN MIEGHEM, Martin PENICKA, Martin MATES, Petr NEMEC, Frank VAN PRAET, Bernard STOCKMAN, Ivan DEGRIEK a Emanuele BARBATO. Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting: the GRAFFITI trial. Eurointervention. Toulouse: Europa edition, 2019, roč. 15, č. 11, s. "E999"-"E1008", 10 s. ISSN 1774-024X. Dostupné z: https://dx.doi.org/10.4244/EIJ-D-19-00463.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting: the GRAFFITI trial
Autoři TOTH, Gabor G. (40 Rakousko), Bernard DE BRUYNE (56 Belgie), Petr KALA (203 Česká republika, domácí), Flavio RIBICHINI (380 Itálie), Filip CASSELMAN (56 Belgie), Ruben RAMOS (620 Portugalsko), Zsolt PIROTH (348 Maďarsko), Stephane FOURNIER (56 Belgie), Anna PICCOLI (380 Itálie), Carlos VAN MIEGHEM (56 Belgie), Martin PENICKA (56 Belgie), Martin MATES (203 Česká republika), Petr NEMEC (203 Česká republika), Frank VAN PRAET (56 Belgie), Bernard STOCKMAN (56 Belgie), Ivan DEGRIEK (56 Belgie) a Emanuele BARBATO (380 Itálie, garant).
Vydání Eurointervention, Toulouse, Europa edition, 2019, 1774-024X.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30201 Cardiac and Cardiovascular systems
Stát vydavatele Francie
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 3.993
Kód RIV RIV/00216224:14110/19:00112632
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.4244/EIJ-D-19-00463
UT WoS 000501563600013
Klíčová slova anglicky fractional flow reserve; multiple vessel disease
Štítky 14110211, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 20. 1. 2020 14:44.
Anotace
Aims: The aim of this study was to assess prospectively the clinical benefits of fractional flow reserve (FFR) in guiding coronary artery bypass grafting (CABG). Methods and results: GRAFFITI is a single-blinded, prospective, multicentre, randomised controlled trial of FFR-guided versus angiography-guided CABG. We enrolled patients undergoing coronary angiography, having a significantly diseased left anterior descending artery or left main stem and at least one more major coronary artery with intermediate stenosis, assessed by FFR. Surgical strategy was defined based on angiography, blinded to FFR values prior to randomisation. After randomisation, patients were operated on either following the angiography-based strategy (angiography-guided group) or according to FFR, i.e., with an FFR <= 0.80 as cut-off for grafting (FFR-guided group). The primary endpoint was graft patency at 12 months. Between March 2012 and December 2016, 172 patients were randomised either to the angiography-guided group (84 patients) or to the FFR-guided group (88 patients). The patients had a median of three [3; 4] lesions; diameter stenosis was 65% (50%; 80%), FFR was 0.72 (0.50; 0.82). Compared to the angiography-guided group, the FFR-guided group received fewer anastomoses (3 [3; 3] vs 2 [2; 3], respectively; p=0.004). One-year angiographic follow-up showed no difference in overall graft patency (126 [80%] vs 113 [81%], respectively; p=0.885). One-year clinical follow-up, available in 98% of patients, showed no difference in the composite of death, myocardial infarction, target vessel revascularisation and stroke. Conclusions: FFR guidance of CABG has no impact on one-year graft patency, but it is associated with a simplified surgical procedure. ClinicalTrials.gov Identifier: NCT01810224
VytisknoutZobrazeno: 26. 8. 2024 14:21